evaluated the U.S. MASH population using medical records to characterize disease features, identify fast-progressing phenotypes, and compare them with late-phase clinical trial cohorts. Methods: A retrospective cohort…
administered in either the first-line or second-line setting. The primary endpoint was progression-free survival (PFS). Secondary endpoints included overall survival (OS), objective response rate (ORR), clinical benefit…